Authors:
Henlin, JM
Boutin, JA
Kucharczyk, N
Desmet-Beaufort, C
Loynel, A
Bertrand, M
Genton, A
Tucker, GC
Atassi, G
Fauchere, JL
Citation: Jm. Henlin et al., From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitors, J PEPT RES, 57(2), 2001, pp. 85-96
Authors:
Guilbaud, N
Kraus-Berthier, L
Meyer-Losic, F
Malivet, V
Chacun, C
Jan, M
Tillequin, F
Michel, S
Koch, M
Pfeiffer, B
Atassi, G
Hickman, J
Pierre, A
Citation: N. Guilbaud et al., Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors, CLIN CANC R, 7(8), 2001, pp. 2573-2580
Authors:
Kostakis, IK
Pouli, N
Marakos, P
Mikros, E
Skaltsounis, AL
Leonce, S
Atassi, G
Renard, P
Citation: Ik. Kostakis et al., Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-ones, BIO MED CH, 9(11), 2001, pp. 2793-2802
Authors:
Chollet, AM
Le Diguarher, T
Murray, L
Bertrand, M
Tucker, GC
Sabatini, M
Pierre, A
Atassi, G
Bonnet, J
Casara, P
Citation: Am. Chollet et al., General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors, BIOORG MED, 11(3), 2001, pp. 295-299
Authors:
Lisowski, V
Enguehard, C
Lancelot, JC
Caignard, DH
Lambel, S
Leonce, S
Pierre, A
Atassi, G
Renard, P
Rault, S
Citation: V. Lisowski et al., Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents, BIOORG MED, 11(16), 2001, pp. 2205-2208
Citation: J. Gusman et al., A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol, CARCINOGENE, 22(8), 2001, pp. 1111-1117
Authors:
Leonce, S
Perez, V
Lambel, S
Peyroulan, D
Tillequin, F
Michel, S
Koch, M
Pfeiffer, B
Atassi, G
Hickman, JA
Pierre, A
Citation: S. Leonce et al., Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in Sphase leading to apoptosis, MOLEC PHARM, 60(6), 2001, pp. 1383-1391
Authors:
Sittisombut, C
Costes, N
Michel, S
Koch, M
Tillequin, F
Pfeiffer, B
Renard, P
Pierre, A
Atassi, G
Citation: C. Sittisombut et al., Synthesis and cytotoxic activity of benzopyranoxanthone analogues of benzo[b]acronycine and psorospermine, CHEM PHARM, 49(6), 2001, pp. 675-679
Authors:
Malonne, H
Farinelle, S
Decaestecker, C
Gordower, L
Fontaine, J
Chaminade, F
Saucier, JM
Atassi, G
Kiss, R
Citation: H. Malonne et al., In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1, CLIN CANC R, 6(9), 2000, pp. 3774-3782
Authors:
Kraus-Berthier, L
Jan, M
Guilbaud, N
Naze, M
Pierre, A
Atassi, G
Citation: L. Kraus-berthier et al., Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice, CLIN CANC R, 6(1), 2000, pp. 297-304
Authors:
Farinelle, S
Malonne, H
Chaboteaux, C
Decaestecker, C
Dedecker, R
Gras, T
Darro, F
Fontaine, J
Atassi, G
Kiss, R
Citation: S. Farinelle et al., Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells, J PHARM TOX, 43(1), 2000, pp. 15-24
Authors:
Lewin, G
Schaeffer, C
Hocquemiller, R
Jacoby, E
Leonce, S
Pierre, A
Atassi, G
Citation: G. Lewin et al., Access to new cytotoxic bisindole alkaloids by a modified borch reductive amination process, HETEROCYCLE, 53(11), 2000, pp. 2353
Authors:
Ghirtis, K
Pouli, N
Marakos, P
Skaltsounis, AL
Leonce, S
Caignard, DH
Atassi, G
Citation: K. Ghirtis et al., Synthesis and conformational analysis of some new pyrano[2,3-c]xanthen-7-one and pyrano[3,2-b]xanthen-6-one derivatives with cytotoxic activity, HETEROCYCLE, 53(1), 2000, pp. 93-106
Authors:
Langer, I
Vertongen, P
Perret, J
Fontaine, J
Atassi, G
Robberecht, P
Citation: I. Langer et al., Expression of vascular endothelial growth factor (VEGF) and VEGF receptorsin human neuroblastomas, MED PED ONC, 34(6), 2000, pp. 386-393
Authors:
Costes, N
Le Deit, H
Michel, S
Tillequin, F
Koch, M
Pfeiffer, B
Renard, P
Leonce, S
Guilbaud, N
Kraus-Berthier, L
Pierre, A
Atassi, G
Citation: N. Costes et al., Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3,2-h]acridin-7-one analogues of acronycine, J MED CHEM, 43(12), 2000, pp. 2395-2402
Authors:
Kostakis, I
Ghirtis, K
Pouli, N
Marakos, P
Alexios-Leandros, S
Leonce, S
Caignard, DH
Atassi, G
Citation: I. Kostakis et al., Synthesis and cytotoxic activity of 2-dialkylaminoethylamino substituted xanthenone and thioxanthenone derivatives, FARMACO, 55(6-7), 2000, pp. 455-460
Authors:
Aligiannis, N
Pouli, N
Marakos, P
Mitaku, S
Skaltsounis, AL
Leonce, S
Pierre, A
Atassi, G
Citation: N. Aligiannis et al., Design, synthesis and biological activity of 7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)daunomycinone and 7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-alpha-L-lyxo-hexopyranosyl)daunomycinone, CHEM PHARM, 48(1), 2000, pp. 150-153
Authors:
Burbridge, MF
Kraus-Berthier, L
Naze, M
Pierre, A
Atassi, G
Guilbaud, N
Citation: Mf. Burbridge et al., Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: Use of the CA125 tumour marker to predict antitumour activity, INT J ONCOL, 15(6), 1999, pp. 1155-1162